erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the
.
.
.
the statistics i�m quoting reveal a problem on the level of a tsunami sweeping across the whole of america and europe.
.
.
.